With Cornell's help, an Amish farmer grows shiitake mushrooms and solves his financial woes, and an entrepreneur and a chef, both from China, use the mushrooms for a sauce that is now on the market.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
Researchers studying artificial intelligence training data and treatment of swelling linked to breast cancer are among the eight Cornell assistant professors who recently received National Science Foundation Faculty Early Career Development Awards.
New York Gov. Kathy Hochul outlined plans for rebuilding the state’s infrastructure Feb. 10 at a New York City event sponsored by Cornell’s Institute of Politics and Global Affairs.
Allison Koenecke, assistant professor of information science at Cornell University, says AI systems do not perform equally for all English speakers, which could negatively impact the hiring process.
Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute to investigate the molecular mechanisms by which immune cells interact with Epstein-Barr virus to cause lymphoma, particularly in people living with HIV.
Researchers studying large-scale artificial intelligence, microbial biomanufacturing and causal inference methods are among the Cornell researchers who recently received National Science Foundation Faculty Early Career Development Awards.
A team has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron. Their discovery could lead to more potent vaccines and new antibody-based treatments.
The Yang-Tan WorkABILITY Incubator, recently launched through the ILR School’s Center for Applied Research on Work, will support innovative applied research projects and collaborations.
